Bortezomib Abolishes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via a p21-Dependent Mechanism in Human Bladder and Prostate Cancer CellsLaura M. Lashinger, David J. McConkey|Cancer Research|2005Cited by 109